Early Exploratory Studies Should Be Conducted in Japan for Japan-originated New Drugs: FPMAJ Chairman Shoda

At lectures held by the Japan CRO Association in Tokyo on November 30, Chairman Takashi Shoda of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) called for an upgrade of the environment for early-stage clinical trials in cooperation with...read more